Smith & Nephew Boosts ENT Portfolio, Acquires Tusker Medical
Smith & Nephew has acquired Tusker Medical for an undisclosed price. The acquisition comes just months after Tusker’s Tula system was approved by the FDA as a breakthrough device.
You may also be interested in...
The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.
November’s approvals include the US FDA approval of Medtronic’s In.Pact AV paclitaxel-coated balloon, for the treatment of arteriovenous access in patients with end-stage renal disease, and a CE mark that expands the indication for Edwards’ Sapien 3 TAVR device to include patients at low-risk during surgery.
Smith & Nephew is continuing its acquisition spree by picking up Leaf Healthcare, the developer of a pressure injury prevention device, to bolster its advanced wound management portfolio.